TVM Capital Life Science has led an €8 million Series A financing round for Myosotis GmbH, a Berlin-based digital healthcare startup, to enhance growth and innovation in digital communication solutions for care homes.

Information on the Target

Myosotis GmbH, commonly referred to as myo, is an innovative digital healthcare startup based in Berlin, founded in 2018. The company aims to enhance communication within care homes by providing digital solutions that foster transparency and encourage participation among employees, families, and service providers. Myo's flagship communication application allows care facilities to connect with relatives effortlessly, share updates through photos and videos, and facilitate video calls. Additionally, the app streamlines administrative tasks such as meal orders and complaint monitoring, improving efficiency and documentation within the care sector. Currently, myo serves approximately 400 customers across the DACH region and the UK.

Industry Overview in Germany

The healthcare industry in Germany is undergoing a significant transformation driven by increasing demands for efficiency and patient-centered care. Recent policy changes, particularly the digitalization strategy implemented by the Ministry of Health, recognize the critical role that digital solutions will play in addressing the challenges faced by the healthcare system. This strategic shift is crucial as it aims to alleviate the pressures on healthcare providers while improving the quality of care delivered to patients.

Within this evolving landscape, the integration of digital tools into everyday healthcare operations is seen as a key driver of innovation. Companies like myo are at the forefront of this change, tapping into the growing trend of digital health technologies that cate